WebDisclosure WebDisclosure
Basculer en Français
11223 Companies
248902 Keywords
176712 Articles
134722 Press releases
Headlines Articles Press releases WALLIX Remove
  1. Home
  2. Companies
  3. WALLIX
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 04/11/2024 at 18:00, 2 years 6 months ago

    Maintien d'une hypercroissance des revenus récurrents au 1er trimestre 2024

    WALLIX annonce une progression de +33,6% du Revenu mensuel récurrent au 31 mars 2024, avec des revenus annuels récurrents de 20,6 M€. Confirmation d'une croissance rentable dès le second semestre 2024
    Cybersécurité Croissance Rentable WALLIX Revenu Mensuel Récurrent Directive NIS 2
    Logo of WALLIX
  • PRESS RELEASE

    published on 04/11/2024 at 18:00, 2 years 6 months ago

    Sustained hypergrowth in recurring business in Q1 2024

    WALLIX (Euronext ALLIX) announces impressive Q1 2024 performance with 33.6% MRR growth and €7.0M turnover. Confirms profitable growth from H2 2024 amidst cybersecurity market dynamics
    Cybersecurity Profitable Growth Q1 2024 WALLIX Euronext ALLIX
    Logo of WALLIX
Previous page
1 ... 32 33
Accesswire
  • Published on 10/24/2026 at 00:25, 5 hours 54 minutes ago

    Caldwell Announces Sale of IQTalent

  • Published on 10/24/2026 at 00:04, 6 hours 15 minutes ago

    Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters

  • Published on 10/23/2026 at 23:30, 6 hours 49 minutes ago

    Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita

  • Published on 10/23/2026 at 21:55, 8 hours 24 minutes ago

    Apex Closes Offering and Completes NASDAQ Listing

  • Published on 10/23/2026 at 16:00, 14 hours 19 minutes ago

    Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award

View all ACCESSWIRE
EQS Group
  • Published on 10/23/2026 at 18:55, 11 hours 24 minutes ago

    Qatar's Years of Culture Initiative Announces Partner Countries Through 2030

  • Published on 10/23/2026 at 18:00, 12 hours 19 minutes ago

    BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL

  • Published on 10/23/2026 at 18:00, 12 hours 19 minutes ago

    ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26

  • Published on 10/23/2026 at 17:55, 12 hours 24 minutes ago

    Tout entendre, sans rien téléverser : VoxNexus lance la première intelligence artificielle (IA) vocale pour Android à écoute continue, à faible consommation et entièrement embarquée

  • Published on 10/23/2026 at 17:55, 12 hours 24 minutes ago

    Hears Everything, Uploads Nothing: VoxNexus Launches Android's First Low-Power On-Device Always-On Voice Artificial Intelligence (AI)

View all EQS
Les Echos
  • Published on 10/23/2026 at 20:33, 9 hours 46 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026

  • Published on 10/23/2026 at 20:33, 9 hours 46 minutes ago

    Disclosure of transactions in own shares from October 19 to October 23, 2026

  • Published on 10/23/2026 at 17:45, 12 hours 34 minutes ago

    Imerys-10-2026-communique-capital-droits-de-vote-au-30-septembre-2026

  • Published on 10/23/2026 at 17:45, 12 hours 34 minutes ago

    Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026

  • Published on 10/23/2026 at 17:45, 12 hours 34 minutes ago

    Klarsen : Comptes semestriels 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy